IRIS
RASI, GUIDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.728
AS - Asia 3.815
EU - Europa 2.942
SA - Sud America 529
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
Totale 34.077
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.626
SG - Singapore 1.971
CN - Cina 845
IT - Italia 460
BR - Brasile 453
UA - Ucraina 411
DE - Germania 398
RU - Federazione Russa 356
HK - Hong Kong 314
IE - Irlanda 281
PL - Polonia 264
FR - Francia 254
VN - Vietnam 247
GB - Regno Unito 147
KR - Corea 118
SE - Svezia 118
FI - Finlandia 114
JP - Giappone 114
CA - Canada 59
NL - Olanda 56
IN - India 51
AR - Argentina 31
MX - Messico 26
BD - Bangladesh 21
UZ - Uzbekistan 20
AT - Austria 19
ID - Indonesia 15
EC - Ecuador 14
IQ - Iraq 14
ZA - Sudafrica 14
TR - Turchia 12
ES - Italia 11
BE - Belgio 10
IR - Iran 10
VE - Venezuela 9
CL - Cile 8
EU - Europa 8
MA - Marocco 8
PK - Pakistan 8
SA - Arabia Saudita 8
AU - Australia 7
EG - Egitto 7
IL - Israele 7
CO - Colombia 6
CZ - Repubblica Ceca 6
PH - Filippine 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
LT - Lituania 5
RO - Romania 5
CH - Svizzera 4
KE - Kenya 4
OM - Oman 4
PT - Portogallo 4
TN - Tunisia 4
TW - Taiwan 4
CR - Costa Rica 3
JO - Giordania 3
KZ - Kazakistan 3
NG - Nigeria 3
PE - Perù 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
DK - Danimarca 2
DM - Dominica 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
LB - Libano 2
LV - Lettonia 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
DZ - Algeria 1
EE - Estonia 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TV - Tuvalu 1
UY - Uruguay 1
Totale 34.077
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.568
Wilmington 7.094
Houston 5.918
Singapore 801
Ann Arbor 757
Fairfield 622
Ashburn 457
Jacksonville 381
Chandler 354
San Jose 353
Beijing 325
Hong Kong 305
Dublin 277
Kraków 251
Seattle 239
Medford 225
Cambridge 224
Dearborn 155
Santa Clara 124
The Dalles 119
Rome 109
Lawrence 99
Los Angeles 94
Tokyo 91
New York 87
Dallas 80
Hangzhou 78
Ho Chi Minh City 73
Zhengzhou 73
Hanoi 67
Mülheim 63
Buffalo 61
Council Bluffs 56
San Diego 47
Moscow 43
Milan 42
Lauterbourg 41
Porto Alegre 36
São Paulo 35
Helsinki 30
Boardman 27
Chicago 26
Toronto 26
Menlo Park 25
London 24
Shanghai 23
Munich 22
Nuremberg 22
Haiphong 20
Falls Church 19
Hefei 19
University Park 18
Columbus 17
Frankfurt am Main 17
Nanjing 17
Verona 17
Chennai 16
Rio de Janeiro 15
San Mateo 15
Norwalk 14
Orem 14
Belo Horizonte 13
North Bergen 13
Redwood City 13
Yongsan-gu 13
Atlanta 12
Warsaw 12
Brooklyn 11
Denver 11
Mountain View 11
San Francisco 11
Seoul 11
Bologna 10
Johannesburg 10
Kunming 10
Fukuoka 9
Guangzhou 9
Jakarta 9
Montreal 9
Tashkent 9
Brussels 8
City of London 8
Curitiba 8
Da Nang 8
Detroit 8
Tampa 8
Amsterdam 7
Boston 7
Chengdu 7
Goiânia 7
Nürnberg 7
Palo Alto 7
Redondo Beach 7
Saint Petersburg 7
Vienna 7
Washington 7
Brasília 6
Brno 6
Guayaquil 6
Las Vegas 6
Totale 28.615
Salva come PNG Salva come JPEG
Nome #
Thymosin alpha 1: from bench to bedside 627
Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies 576
Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance 552
Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer 538
Vaccination with a synthetic nonapeptide expressed in human tumors prevents colorectal cancer liver metastases in syngeneic rats 532
ANTITUMOR EFFECT OF COMBINED TREATMENT WITH THYMOSIN ALPHA-1 AND INTERLEUKIN-2 AFTER 5-FLUOROURACIL IN LIVER METASTASES FROM COLORECTAL-CANCER IN RATS 502
Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1 498
Survivin-Igm Immuno Complex: A Novel Candidate Biomarker Of Cirrhosis To Monitor Patients Progression Towards Hepatocellular Carcinoma 498
Combination low-dose lymphoblastoid interferon and thymosin alpha(1) therapy in the treatment of chronic hepatitis B 485
Feasibilty of in utero DNA vaccination following naked gene transfer into pig fetal muscle: transgene expression, immunity and safety 484
Anti-proliferative effect of atrial natriuretic peptide on colorectal cancer cells: evidence for an Akt-mediated cross-talk between NHE-1 activity and Wnt/β-catenin signaling 482
Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma 478
The risks of risk aversion in drug regulation 467
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis 465
Cancer drug development and the evolving regulatory framework for companion diagnostics in the European union 464
Access to patient-level trial data--a boon to drug developers 464
TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death. 463
Combined treatment with thymosin-alpha 1 and low dose interferon-alpha after dacarbazine in advanced melanoma 462
Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma 455
Anti-tumour immunogens and vaccines 450
Drug policy for an aging population--the European Medicines Agency's geriatric medicines strategy 444
Combination low-dose lymphoblastoid interferon and thymosin α1 therapy in the treatment of chronic hepatitis B 442
Treatment of aspergillus infection with thymosin alpha 1 442
Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis 436
Vaccination with a synthetic nonapeptide expressed in human tumors prevents colorectal cancer liver metastases in syngeneic rats 434
Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling 430
Combination therapy with BRMs in cancer and infectious diseases 427
The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation 426
Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application 424
An audience with Guido Rasi. Interview by Asher Mullard 421
Combination thymosin alpha(1) and lymphoblastoid interferon treatment in chronic hepatitis C 419
Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma 419
High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma 418
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a 415
comparative cellular signal patway analysis of metastatic colorectal cancer in human and preclinical animal model 409
Thymosin alpha1 activates the TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo 407
up-regulation of melanocytic differentiation antigens induced by cyanidin-3-o--glucopyranoside in human melanoma cells. 405
Microfabricated biocapsules provide short-term immunoisolation of insulinoma xenografts 403
ACTIVATION OF HUMAN ENDOGENOUS RETROVIRUS-K AND PRODUCTION OF INFECTIOUS VIRUS-LIKE PARTICLES IN HUMAN MELANOMA CELLS ABS -0153 400
Stimulatory effect of Eucalyptus essential oil on innate cell-mediated immune response 398
Evaluation of antigen specific recognition and cell mediated cytotoxicity by a modified lysispot assay in a rat colon carcinoma model 395
Straight talk with...Guido Rasi. Interview by Roxanne Khamsi 394
early detection of molecular markers suitable for colorectal cancer diagnosis and therapy in a carcinogenesis model 393
Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional healthcare providers 391
Differentiation of human melanoma cells induced by cyanidin-3-O-beta-glucopyranoside 389
differentiation therapy: in vitro evidence making cyanidin-3-o--glucopiranoside useful for prevention and treatment of melanoma 389
nerve growth factor (ngf) and cirrhosis: a possible new marker of progression to hepatocellular carcinoma (hcc) 388
Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee 388
Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma 388
Fifty years after thalidomide; what role for drug regulators? 387
null 385
COMPARATIVE CELLULAR SIGNAL PATWAY ANALYSIS OF METASTATIC COLORECTAL CANCER IN HUMAN AND PRECLINICAL ANIMAL MODEL 383
null 380
Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance. 380
Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha 1 and interleukin-2 after intraperitoneal 5-fluorouracil delivery 376
Method of up-regulating tumor antigen expression using thymalfasin 373
Preclinical studies using oncofidä-s, a new sn38-hyaluronic acid bioconyugate, for cd44-targeted therapy of colon carcinoma 373
Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice 371
preventive peptide vaccine for colorectal cancer metastases 368
Characterization of four newly established melanoma cell lines 368
Influenza della concentrazione di adriamicina su modificazioni volumetriche e proliferazione di cellule leucemiche in vitro 368
up-regulation of melan-a/mart-1 antigen expression during human melanoma cell differentiation 366
Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms 361
nerve growth factor (ngf): a possible marker for hepatocellular carcinoma (hcc)? 358
null 342
WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer 330
Stimolazione in vivo mediante prostaglandine ed interferone dell'attività natural killer in topi trattati con ciclofosfamide. vol. 87, p. 595-603 320
Rationale for therapeutic approaches with thymic hormones, interleukin 2 and interferon in combination with chemotherapy. 318
A new tumour associated antigen of non-small cell lung cancer: Tumour Liberated Proteins (TLP) - A possible new tumor marker 261
Metformin induces apoptosis and downregulates pyruvate kinase M2 in breast cancer cells only when grown in nutrient-poor conditions 257
A new tumour associated antigen of non-small cell lung cancer: Tumour liberated proteins (TLP) - A possible new tumor marker 230
Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: A phase-II controlled trial 215
Sequential biochemotherapy for metastatic colorectal cancer using, fluorouracil, folinic acid, thymopentin and interleukin-2: Clinical and immunological effects 196
BIOCHEMOTHERAPY WITH THYMOSIN-ALPHA-1, INTERLEUKIN-2 AND DACARBAZINE IN PATIENTS WITH METASTATIC MELANOMA - CLINICAL AND IMMUNOLOGICAL EFFECTS 195
Open clinical trial data for all? A view from regulators 195
Clinical trial publications: A sufficient basis for healthcare decisions? 175
Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation 170
Asthma, allergy and the olympics: A 12-year survey in elite athletes 167
From adaptive licensing to adaptive pathways: Delivering a flexible life-span approach to bring new drugs to patients 154
Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity 147
Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma 146
Big Data – How to Realize the Promise 143
Preliminary evidence of the differential expression of human endogenous retroviruses in Kawasaki disease and SARS-CoV-2-associated multisystem inflammatory syndrome in children 135
Innovative medicines: New regulatory procedures for the third millennium 134
Transparency and the European medicines agency - Sharing of clinical trial data 127
How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory-HTA parallel scientific advice 126
First-in-human clinical trials - What we can learn from tragic failures 126
Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals? 126
European regulatory experience with drugs for central nervous system disorders 120
The impact of parallel regulatory–health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations 119
preventive peptide vaccine for colorectal cancer metastases 116
Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward 116
Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves 108
Drug regulation and pricing - Can regulators influence affordability? 106
High CD169 monocyte/lymphocyte ratio reflects immunophenotype disruption and oxygen need in COVID-19 patients 105
Steps forward in regulatory pathways for acute and chronic heart failure 104
Inhibitor of fatty acid amide hydrolase: learning from tragic failures [The editorialists reply] 100
High CD169 Monocyte/Lymphocyte Ratio Reflects the Immunophenotyping Disruption and Predicts Oxygen Need in COVID-19 Patients 97
Characterization of three melanoma cell lines (TVM-A12, TVM-A-197, TVM-BO): Sensitivity to lysis and effect of retinoic acid 91
Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics 89
Totale 33.479
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.363
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021228 0 0 0 0 0 0 0 0 0 0 185 43
2021/2022977 32 113 45 26 24 92 77 38 94 67 57 312
2022/20231.150 127 53 45 120 91 292 97 79 81 12 129 24
2023/2024317 40 8 31 18 30 67 11 11 2 11 13 75
2024/20252.991 69 585 319 136 51 223 121 145 256 245 441 400
2025/20263.504 320 173 449 256 334 101 416 539 447 430 39 0
Totale 34.288